about
WNT5A is a regulator of fibroblast proliferation and resistance to apoptosisEgr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease.Transcriptome analysis reveals differential splicing events in IPF lung tissuePPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesisOptimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis.Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertensionThe K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosisEarly growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling.Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF.Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice.Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma.Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis.Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung diseaseLysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis.Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis.Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis.An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model.Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling.Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts.Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro.Fibroblasts that resist cigarette smoke-induced senescence acquire profibrotic phenotypes.Transcriptome analysis reveals differential splicing events in IPF lung tissue.Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy.Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts.Novel classification for global gene signature model for predicting severity of systemic sclerosis.Molecular Profiling Of Lung Tissues And Primary Fibroblasts From Patients With Systemic Sclerosis
P50
Q24316338-8D8AA4D4-DC19-449A-B1F4-3DCDD931F050Q33373335-4481822A-2A1E-4DC8-9585-852508FF9FA8Q33578527-20AB8740-AD2D-47CF-95EF-86FFD74FAD9BQ33745028-80BC296A-EF3B-4568-93DC-9C109BB79CAFQ33834728-4F6522EA-A0B0-4292-99BE-046451159610Q34840778-9ADC42EE-2F77-4C1D-81BE-C0590596B8CBQ35083097-28B63048-5137-453D-ACDA-752E9CFFC139Q35101753-698299B7-BB69-432F-89EA-429238E5D225Q35108749-F7CB1711-F2CC-4061-943D-751186DD5A6AQ35121494-3CCC9CAD-2D8E-489E-AAD2-227B4CCA1B0EQ35672107-80554A64-9ECD-461E-A352-D4EB7490BA86Q35770782-33179569-4F94-4E7E-8F21-480EB399A9CAQ36503865-AA89C254-4DAA-4BF9-A38D-0763C120D598Q36511520-FE929252-91D8-4EE1-B656-B0DFAEE37521Q36605083-E6EEE0D5-DED0-441C-A276-9760F04DCE95Q36778823-A89719CA-09CA-4D4F-8EBE-26637F0D9E28Q36888302-074B13A2-6F21-4A72-93E4-B800FA48467CQ36891532-92DAFCAA-D4B6-484B-B0C0-4A1AA43F59E2Q37503878-6B776FFE-132D-43CE-B4CA-7EE94281BA5CQ37635850-C107A8FA-A7DB-473D-846E-FFA915362330Q38656832-E9C5A60A-73AD-45CF-BB73-FB9C42071863Q38914965-9924A223-B33D-44AF-BEC5-BABDB10B9B0FQ38956376-081D8BAC-D9A8-49E9-8DAB-300D58CD90E1Q39408458-79F09A1F-89A5-4668-AF87-CB0A24DA225BQ39492601-34564303-B653-473D-B904-B5D04E309820Q41057314-97AE9F7A-1164-4D04-8C33-2B9037CB6DFCQ41573646-C5E1CC7C-4208-412E-AF8E-285691A4A0F8Q41921136-35A4F1BF-7F46-4297-97EA-1FE0D3750B37Q42603143-F362ACFC-F98E-41A7-88D3-FE80AC5583B2Q44614511-735195BA-ADAF-4D37-BD86-5A439DF3B511Q46210458-989275C4-2117-42ED-AF8B-BF7BDF286A52Q46387801-2621022C-1880-4AF3-98F2-6AB9CFF0835AQ47788087-00F5904D-BA81-45D6-B0E6-54AF1E4FE3A1Q48004214-06D84134-775E-49FE-B296-C8BF360D5EFFQ48094614-1CDE13DB-C5C9-439E-8C18-ABD24C8C6CF5Q52648646-884DA2A6-9DAE-4704-9ACA-F495C76AD4B7Q52923519-B834806C-C48B-4577-A85D-ABA3C0497B59Q53884287-9D217D87-5E35-484E-AE30-52E93E415C31Q55490826-63DE9B74-0596-49A9-8B39-7BA9C0C106C5Q57775551-45904C28-9275-4DD4-9136-E5BEFC361CCB
P50
description
researcher ORCID ID = 0000-0002-6750-6407
@en
wetenschapper
@nl
name
Carol Feghali-Bostwick
@ast
Carol Feghali-Bostwick
@en
Carol Feghali-Bostwick
@es
Carol Feghali-Bostwick
@nl
type
label
Carol Feghali-Bostwick
@ast
Carol Feghali-Bostwick
@en
Carol Feghali-Bostwick
@es
Carol Feghali-Bostwick
@nl
prefLabel
Carol Feghali-Bostwick
@ast
Carol Feghali-Bostwick
@en
Carol Feghali-Bostwick
@es
Carol Feghali-Bostwick
@nl
P106
P2038
Carol_Feghali-Bostwick
P31
P496
0000-0002-6750-6407